Effects of ORG 2766, a neurotrophic ACTH4-9 analogue, in neuroblastoma cells.
Treatment of Neuro2a cells with drugs known to affect the integrity of microfilaments and microtubules, as well as with a calcium ionophore produced damage to the cellular membrane that was quantifiable by measuring the release of LDH into the culture medium. Concurrent exposure of the cells to ORG 2766 was found to modulate the release of LDH in a dose- and time-dependent fashion. ORG 2766 treatment was also able to reduce the basal release of LDH into the culture medium. [table: see text] The ORG 2766-induced reduction in LDH release was not due to down-regulation of protein synthesis. The peptide produced significant increases in protein synthesis relative to control conditions at concentrations of 10(-11) to 10(-6) M with 10(-8) M being an optimal dose. SDS-PAGE and 2-D PAGE analysis showed that de novo synthesis of most polypeptides was increased by about 40%. Additionally, a family of polypeptides tentatively identified as actins appear to undergo ORG 2766-dependent post translational charge modifications. These data are consistent with the hypothesis that regulation of transcription and/or translation are mechanisms important to the neurotrophic actions of ORG 2766.
Murry
R
R
Graduate Neuroscience Program, Loyola University Stritch School of Medicine, Maywood, Illinois 60153.
McLane
J A
JA
Gruener
G
G
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D015415:Biomarkers; D000001:Calcimycin / Q000633:toxicity; D003078:Colchicine / Q000633:toxicity; D015638:Cytochalasin D / Q000633:toxicity; D015180:Electrophoresis, Gel, Two-Dimensional; D004591:Electrophoresis, Polyacrylamide Gel; D007770:L-Lactate Dehydrogenase / Q000032:analysis*; D008715:Methionine / Q000378:metabolism; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000302:isolation & purification; D009447:Neuroblastoma; D009498:Neurotoxins / Q000633:toxicity*; D010446:Peptide Fragments / Q000494:pharmacology*; D013462:Sulfur Radioisotopes; D014407:Tumor Cells, Cultured; D014750:Vincristine / Q000633:toxicity
D000927:Anticonvulsants; D015415:Biomarkers; D009363:Neoplasm Proteins; D009498:Neurotoxins; D010446:Peptide Fragments; D013462:Sulfur Radioisotopes; D015638:Cytochalasin D; D000001:Calcimycin; C013765:Org 2766; D014750:Vincristine; D000324:Adrenocorticotropic Hormone; D008715:Methionine; D007770:L-Lactate Dehydrogenase; D003078:Colchicine